Next Article in Journal
The Impact of Medical Physical Training and a Structured Personalized Exercise Training Program on Hemodynamic Parameters and Arterial Stiffness in Pregnant Women
Next Article in Special Issue
Point-of-Care Serum Proenkephalin as an Early Predictor of Mortality in Patients Presenting to the Emergency Department with Septic Shock
Previous Article in Journal
Chemerin Levels in Individuals with Type 2 Diabetes and a Normal Weight versus Individuals with Type 2 Diabetes and Obesity: An Observational, Cross-Sectional Study
Previous Article in Special Issue
Cell-Free Nuclear and Mitochondrial DNA as Potential Biomarkers for Assessing Sepsis Severity
 
 
Review
Peer-Review Record

Recent Data about the Use of Corticosteroids in Sepsis—Review of Recent Literature

Biomedicines 2024, 12(5), 984; https://doi.org/10.3390/biomedicines12050984
by Alexandra Lazar
Reviewer 1: Anonymous
Reviewer 2:
Biomedicines 2024, 12(5), 984; https://doi.org/10.3390/biomedicines12050984
Submission received: 28 March 2024 / Revised: 23 April 2024 / Accepted: 28 April 2024 / Published: 30 April 2024
(This article belongs to the Special Issue Molecular Biomarkers and More Efficient Therapies for Sepsis)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

This is a very interesting narrative review by Alexandra Lazar concerning the ambiguous effects of systemic corticosteroids in sepsis and septic shock. It is true that the use of corticosteroids as adjunctive treatment for sepsis has remained a very controversial topic. Although a systematic review and meta-analysis would be preferable the present paper summarizes rather adequately the recent data on the use of corticosteroids in sepsis and septic shock. However, I have two major comments:

1.       I think that the inclusion criteria should be stated more precisely. For example, why was the following study by Marik et al ignored:

Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017 Jun;151(6):1229-1238. doi: 10.1016/j.chest.2016.11.036.   

2. In my opinion the discussion section should be more extensive including a more critical view of the data. Arguments against the use of corticosteroids in sepsis are missing

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The utilization of glucocorticoids in sepsis is aimed at alleviating the excessive inflammation, potentially averting further tissue damage and enhancing outcomes. Nevertheless, the clinical evidence regarding their effectiveness is inconclusive, as some studies suggest benefits in specific patient subsets while others indicate no significant impact or even adverse effects.

The review by Lazar is somewhat unbalanced in the sense that 6/14 pages of text are devoted to tables with data from the literature. Maybe reconsider moving some stuff from the tables to the text.....

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

I think that the authors have adequately addressed my comments in the revised version of the manuscript. Therefore, I have no further comments.

Back to TopTop